150 related articles for article (PubMed ID: 8071968)
21. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
22. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
23. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1.
Rahman N; Abidi F; Ford D; Arbour L; Rapley E; Tonin P; Barton D; Batcup G; Berry J; Cotter F; Davison V; Gerrard M; Gray E; Grundy R; Hanafy M; King D; Lewis I; Ridolfi Luethy A; Madlensky L; Mann J; O'Meara A; Oakhill T; Skolnick M; Strong L; Stratton MR
Hum Genet; 1998 Nov; 103(5):547-56. PubMed ID: 9860296
[TBL] [Abstract][Full Text] [Related]
24. Familial Wilms' tumor associated with a WT1 zinc finger mutation.
Kaplinsky C; Ghahremani M; Frishberg Y; Rechavi G; Pelletier J
Genomics; 1996 Dec; 38(3):451-3. PubMed ID: 8975729
[No Abstract] [Full Text] [Related]
25. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
[TBL] [Abstract][Full Text] [Related]
27. Familial Wilms' tumor: a descriptive study.
Breslow NE; Olson J; Moksness J; Beckwith JB; Grundy P
Med Pediatr Oncol; 1996 Nov; 27(5):398-403. PubMed ID: 8827065
[TBL] [Abstract][Full Text] [Related]
28. Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma.
Brodeur GM
Cancer Surv; 1995; 25():67-99. PubMed ID: 8718513
[TBL] [Abstract][Full Text] [Related]
29. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
[TBL] [Abstract][Full Text] [Related]
30. Teratoid Wilms' tumour occurring synchronously with classical Wilms' tumour in Beckwith Wiedemann syndrome.
Paterson A; Sweeney LE
Pediatr Radiol; 2000 Sep; 30(9):656-7. PubMed ID: 11009309
[No Abstract] [Full Text] [Related]
31. Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
Birch JM; Alston RD; McNally RJ; Evans DG; Kelsey AM; Harris M; Eden OB; Varley JM
Oncogene; 2001 Aug; 20(34):4621-8. PubMed ID: 11498785
[TBL] [Abstract][Full Text] [Related]
32. [A French genetic and epidemiologic study on nephroblastoma: preliminary results].
Bonaïti-Pellié C; Chompret A; Tournade MF; Zucker JM; Lemerle J
Bull Cancer; 1988; 75(1):131-3. PubMed ID: 2833963
[TBL] [Abstract][Full Text] [Related]
33. Wilms' tumour and parental age: a report from the National Wilms' Tumour Study.
Olson JM; Breslow NE; Beckwith JB
Br J Cancer; 1993 Apr; 67(4):813-8. PubMed ID: 8385980
[TBL] [Abstract][Full Text] [Related]
34. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
35. Identification of new Wilms tumour predisposition genes: an exome sequencing study.
Mahamdallie S; Yost S; Poyastro-Pearson E; Holt E; Zachariou A; Seal S; Elliott A; Clarke M; Warren-Perry M; Hanks S; Anderson J; Bomken S; Cole T; Farah R; Furtwaengler R; Glaser A; Grundy R; Hayden J; Lowis S; Millot F; Nicholson J; Ronghe M; Skeen J; Williams D; Yeomanson D; Ruark E; Rahman N
Lancet Child Adolesc Health; 2019 May; 3(5):322-331. PubMed ID: 30885698
[TBL] [Abstract][Full Text] [Related]
36. [Urogenital malformations associated with Wilms' tumor. Molecular genetic and clinical aspects].
Zugor V; Schott GE
Urologe A; 2007 Feb; 46(2):146, 148-9. PubMed ID: 17226050
[TBL] [Abstract][Full Text] [Related]
37. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
[TBL] [Abstract][Full Text] [Related]
38. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.
Begent J; Sebire NJ; Levitt G; Brock P; Jones KP; Ell P; Gordon I; Anderson J
Eur J Cancer; 2011 Feb; 47(3):389-96. PubMed ID: 21074411
[TBL] [Abstract][Full Text] [Related]
40. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.
Scott RH; Stiller CA; Walker L; Rahman N
J Med Genet; 2006 Sep; 43(9):705-15. PubMed ID: 16690728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]